Literature DB >> 22572705

Metabonomic investigation on the protective effects of rosiglitazone and caloric restriction for renal senescence in a rat model.

Yingwei Zhang1, Shikai Yan, Xiang Gao, Weixing Dai, Senyan Liu, Huizi Jin, Weidong Zhang, Changlin Mei.   

Abstract

BACKGROUND AND AIMS: A liquid chromatography coupled with mass spectrometry based metabonomics approach was applied to investigate the protective effects of rosiglitazone (RGTZ) and caloric restriction (CR) for renal senescence in a rat model.
METHODS: Kidney tissues and serum samples were collected from four groups of rats, including 12- month and 24-month ad libitum fed rats, RGTZ and CR treated 24-month rats. Multivariate data analysis was performed on the mass data of metabonomic profiles to detect the differences among the groups.
RESULTS: By metabolite profiling and partial least squares discriminate analysis, 23 renal senescence-related endogenous metabolites were discovered, including phospholipids, carnitine, acetylcarnitine, and creatinine, most of which were related to the oxidative stress and lipid metabolism.
CONCLUSION: Renal senescence is characterized by oxidative stress and changes in lipid metabolism, and RGTZ administration and CR treatment may have similar protective effects for renal senescence via restraining oxidative stress and lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572705     DOI: 10.3275/8409

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  2 in total

Review 1.  Calorie restriction and its impact on gut microbial composition and global metabolism.

Authors:  Xiaojiao Zheng; Shouli Wang; Wei Jia
Journal:  Front Med       Date:  2018-11-16       Impact factor: 4.592

2.  Protective effect of rosiglitazone on microscopic and oxidative stress parameters of ram sperm after freeze-thawing.

Authors:  Mahdieh Mehdipour; Hossein Daghigh-Kia; Abouzar Najafi; Zohreh Mehdipour; Hossein Mohammadi
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.